Navigate the full program across two days of
clinical excellence and research innovation
Schedule
Program
Filter by day to find sessions that matter most to your research and clinical practice
Day 1: Oct 9
Day 2: Oct 10
Friday, October 9
Radisson Collection Hotel — Rävala Street 3, Tallinn
9:00 -- 10:00
Registration
Radisson Collection Hotel
Rävala Street 3, Tallinn
10:00 - 10:10
Welcome
Dr. Pentti Põder, Estonia
I Session
10:10 - 11:20
Heart Failure Today:
Epidemiology and Guideline Updates
Moderators:
Dr. Pentti Põder, Estonia
Prof. Diana Žaliaduonytė, Lithuania
10.10–10.30
Heart failure epidemiology: prevalence, risk factors, and future trends
Dr. Märt Elmet, Estonia
10.30-11.00
Evolving standards in heart failure management: what has changed in the latest guidelines?
Dr. Pentti Põder, Estonia
11.00–11.20
Heart failure in daily practice in Baltic countries: lessons from EVOLUTION trial data
Prof. Diana Žaliaduonytė, Lithuania
11.20–11.40
Coffee break
II session
11.40–13.10
Heart failure diagnostics and treatment: challenges and contemporary solutions — part 1
Moderators: Prof. Piotr Ponikowski, Poland; Dr. Ginta Kamzola, Latvia
Debate “Is echocardiography required before initiating heart failure therapy?”
11.40–11.50
Yes
Dr. Ginta Kamzola, Latvia
11.50–12.00
No
Dr. Pentti Põder, Estonia
12.00–12.10
Discussion
12.10–12.40
Managing iron deficiency in heart failure: the emerging role of IV iron therapy
Prof. Piotr Ponikowski, Poland
IV iron therapy: where are we now in Baltics - and what is still holding us back?
12.40–12.45
Estonia
Dr. Marit Märk
12.45–12.50
Latvia
Dr. Baiba Barone
12.50–12.55
Lithuania
Prof. Egle Rumbinaite
12.55–13.10
Discussion
13:10 - 14:00
Lunch Break
III session
14.00–15.20
„Cardiac amyloidosis in 2026: from early detection to advanced management“
Moderators: Dr. Anna Maria Punab, Estonia; Prof. Eglė Ereminienė, Lithuania
14.00–14.20
CMR in the assessment of diseased myocardium: focus on infiltrative cardiomyopathies
Dr. Andrei Šamarin, Estonia
14.20–14.40
ATTR cardiac amyloidosis: diagnosis and opportunities for earlier recognition – real-world experience from the Czech Republic
Prof. Tomáš Paleček, Czechia
14.40–15.00
Contemporary management of ATTR-CM: the evolving therapeutic landscape
Prof. Diana Bonderman, Austria
15.00–15.20
Cardiac amyloidosis in the Baltic States: diagnostic and treatment pathways
Prof. Eglė Ereminienė, Lithuania
15.20–15.40
Coffee Break
IV session
15.40–17.25
Cardiac pacing and heart failure
Moderators: Dr. Kaspars Kupics, Latvia; Assoc. prof. Priit Kampus, Estonia
15.40–16.10
Conduction system pacing (CSP) and heart failure, is there a place for CRT?
Dr. Heli Tolppanen, Finland
Round table: Implementation of CSP in the Baltics
16.10–16.15
Estonia
Dr. Jüri Voitk
16.15–16.20
Latvia
Dr. Evija Kanašniece
16.20–16.25
Lithuania
Dr. Gediminas Račkauskas
16.25–16.30
Finland
Dr. Heli Tolppanen
16.30–16.45
Discussion
16.45–17.05
ICD in non-ischemic cardiomyopathy – is there still a place for primary prevention?
Dr. Silver Heinsar, Estonia
17.05–17.25
Leadless pacing in 2026 – how to choose pacing strategy in younger patients?
Dr. Mantė Agnė Rimkienė, Lithuania
17.25–17.45
Coffee break
17.45–18.45
Satellite symposium (Boehringer Ingelheim)
„Myocardial steatosis and the „healthy“ heart: a hidden path to heart failure"
Moderator: Dr. Pentti Põder, Estonia
19.00–22.00
Dinner at MEKK Restaurant & Bar
Radisson Collection Hotel I floor
